Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
For healthcare providers especially pharmacists, nurses and physicians, we work to provide current information on drug updates, changes in the marketplace, and hot topics in the pharmacy industry.... more
FAQs about The Rx Daily Dose:How many episodes does The Rx Daily Dose have?The podcast currently has 87 episodes available.
December 08, 2020Episode 47 - Oxlumo, Imcivree, & New EUAsIn today's episode we’ll discuss the approval of Oxlumo for primary hyperoxaluria type 1, and approval of Imcivree for chronic weight management. The FDA also issued 2 EUAs for combination treatments for COVID. Don't forget to like, share, and subscribe! Enjoy!...more16minPlay
November 23, 2020Episode 46 - Zokinvy and BanlamivimabIn today's episode we’ll discuss the approval of Zokinvy for Hutchinson-Gilford progeria syndrome, and an EUA for banlamivimab, a monoclonal antibody treatment for COVID19. As always feel free to skip around, I'm going to including times in the show notes so you can get the drugs that interest you. Don't forget to like, share, and subscribe! Enjoy!...more12minPlay
November 04, 2020Episode 45 - Veklury & InmazebWe’ll discuss just two things this week - the big item is the approval of Veklury as a treatment for COVID19 and also the approval of Inmazeb, the first treatment for Ebola infection. Don't forget to like, share, and subscribe! Enjoy!...more14minPlay
October 12, 2020Episode 44 - Opdivo, Nucala, & XeljanzWe don’t have any new products on the market to talk about, but we are going to discuss the approval of the combination Opdivo and Yervoy for treating mesothelioma, and new indication approvals for Nucala and Xeljanz. We'll also talk about a new age group for Kalydeco for treating cystic fibrosis. Don't forget to like, share, and subscribe! Enjoy!...more15minPlay
September 21, 2020Episode 43 - Gavreto, Qdolo, & TrulicityIn today's episode, we’re going to talk about the approval of Gavreto, a new gene specific treatment for non-small cell lung cancer, and approval of Qdolo a new oral solution for pain management. We’ll also be discussing approval of new dosing guidelines for Trulicity which will also prompt new strengths available on the market. Don't forget to like, share, and subscribe! Enjoy!...more9minPlay
September 08, 2020Episode 42 - Enspryng, Onureg, & SogroyaIn todays episode were going to talk about the approval of Enspryng for adult patients with NMOSD, and approval of Onureg for acute myeloid leukemia. Well also talk about Winlevi, a new treatment for acne and approval of Sogroya a once-weekly treatment for adults with growth hormone deficiency.Don't forget to like, share and subscribe! Enjoy!...more14minPlay
August 17, 2020Episode 41 - Monjuvi, Evrysdi, & ViltepsoIn today's episode were going to talk about the approval of Monjuvi for B-cell lymphoma, Lampit for Chagas Disease, and Evrysdi for spinal muscular atrophy. We also have approval of Blenrep for multiple myeloma, and Viltepso for Duchenne Muscular Dystrophy. Don't forget to like, share and subscribe! Enjoy!...more16minPlay
August 03, 2020Episode 40 - Breztri, Xywav, & TecartusIn today's episode we're going to talk first about the ongoing COPD triplet wars - with the most recent approval of Breztri for maintenance treatment of patients with chronic obstructive pulmonary disease. We'll also talk about the approval Xywav to treat cataplexy, Xeglyze for head lice, and we’ll also bring up approval of Tecartus, a new CAR-T therapy. Don't forget to like, share, and subscribe! Enjoy!...more15minPlay
July 13, 2020Episode 39 - Rukobia, Inqovi, & UpneeqIn todays episode we're going to talk about the approval of Rukobia, for treatment experienced patients with HIV, and Inqovi for the treatment of specific types of MDS. We'll also talk about the approval of Upneeq which will be used to treat acquired blepharoptosis. Don't forget to like, share, and subscribe! Enjoy!...more12minPlay
July 06, 2020Episode 38 - Crysvita, Fintepla, & PhesgoIn todays episode we're going to talk about the approval of Crysvita for tumor-induced osteomalacia and approval of Fintepla for Dravet syndrome. We'll also talk about approval of Phesgo for HER-2 positive breast cancer, and Dojolvi to treat rare genetic disorders that involve long-chain fatty acid oxidation. Don't forget to like, share and subscribe! Enjoy!...more14minPlay
FAQs about The Rx Daily Dose:How many episodes does The Rx Daily Dose have?The podcast currently has 87 episodes available.